Stanford Researchers Weigh In as Research Peptides Go Mainstream

Stanford Medicine pathologists Katrin Svensson and Jonathan Long address the gap between laboratory peptide research and the growing gray market, stressing that most researchgrade peptides lack human safety and efficacy data.

For research use only. Not for human consumption.